addition of lenalidomide to patients with myeloma progressing on ruxolitinib and methylprednisolone
Published 8 months ago • 166 plays • Length 2:07Download video MP4
Download video MP3
Similar videos
-
1:57
treatment options for patients with multiple myeloma refractory to lenalidomide
-
2:51
ruxolitinib in combination with abemaciclib for patients with primary or post-pv/et myelofibrosis
-
2:26
lenalidomide as post-autosct maintenance therapy for multiple myeloma
-
3:59
addressing the unmet need for patients with lenalidomide-refractory multiple myeloma
-
1:09
an update on alliance a061202: addition of ixazomib to pomalidomide-dexamethasone in r/r myeloma
-
1:02:03
understanding blood-based testing in multiple myeloma with ola landgren, md, phd
-
7:43
exploring a therapy called jakafi® (ruxolitinib)
-
3:25
belantamab mafodotin and its place in myeloma treatment
-
0:45
majestec-2 update: teclistamab plus lenalidomide in r/r multiple myeloma
-
2:49
approaching lenalidomide-refractory multiple myeloma: unmet needs and ongoing trials
-
3:35
a trial investigating the addition of blinatumomab to consolidation chemotherapy in ph- all
-
2:29
evaluating the combination of nivolumab and lenalidomide in relapsed hl and lbcl
-
1:29
the future of adcs in treating multiple myeloma
-
1:33
the role of allogeneic transplantation in patients with multiple myeloma
-
2:55
the addition of bortezomib to melphalan-based conditioning in multiple myeloma
-
8:40
lenalidomide, mutations & mds outcomes
-
1:22
an all-molecular diagnostic approach for myeloma
-
0:45
car t-cell therapy in lenalidomide-refractory multiple myeloma
-
2:22
myeloma xi trial: lenalidomide maintenance therapy for multiple myeloma
-
2:25
pre-clinical activity of ucartcs1 in multiple myeloma
-
3:13
how to optimally sequence agents in the expanding treatment armamentarium of multiple myeloma
-
3:00
processes leading to the development of hyperdiploidy in multiple myeloma